Download PDF
Zentralbl Chir 2012; 137(3): 248-256
DOI: 10.1055/s-0031-1284047
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Pleuraempyem und Lungenabszess: Aktuelle Therapiekonzepte

Pleural Empyema and Lung Abscess: Current Treatment Options
E. Hecker
1   Thoraxzentrum Ruhrgebiet, Klinik für Thoraxchirurgie, Herne, Deutschland
,
S. Hamouri
2   Jordan University of Science and Technology, Department of Surgery, Irbid, Jordan
,
E. Müller
3   Thoraxzentrum Ruhrgebiet, Klinik für Anästhesiologie, Intensiv- und Notfallmedizin, Herne, Deutschland
,
S. Ewig
4   Thoraxzentrum Ruhrgebiet, Klinik für Pneumologie, Infektiologie und Beatmungsmedizin, Herne, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
18 June 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das parapneumonische Pleuraempyem wurde unter verschiedensten Aspekten in Stadien eingeteilt (American Thoracic Society [ATS] –  Einteilung nach der natürlichen Verlaufsform; Light-Klassifikation – Einteilung nach der Zusammensetzung des Ergusses / Empyem; American College of Chest Physicians [ACCP] – Einteilung nach Risikokategorie für ein schlechtes Ergebnis). Die Behandlung des Pleuraempyems soll in allen Einteilungen adaptiert an das jeweilige Stadium erfolgen. Das therapeutische Spektrum umfasst die alleinige Dränagenbehandlung, die Dränagentherapie mit Fibrinolytika, das thorakoskopische Debridement und die Dekortikation in offener bzw. minimalinvasiver Technik. Primäre Lungenabszesse entstehen in gesundem Lungengewebe und sind häufig Ausdruck einer Aspiration. Darüber hinaus kommen auch Abszesse ohne Aspiration vor. Zudem sind ambulant und nosokomial erworbene Abszesse sowie solche unter Immunsuppression zu unterscheiden. 90 % aller Lungenabszesse heilen unter adäquater Antibiotikatherapie folgenlos aus, 10 % benötigen eine interventionelle Katheter- oder Dränagebehandlung, nur 1 % benötigen eine thoraxchirurgische Behandlung aufgrund von Abszesskomplikationen unabhängig vom zuvor durchgeführten konservativen oder interventionellen Verfahren.

Abstract

Parapneumonic pleural empyema has been classified into different stages and classes. While the American Thoracic Society (ATS) classification is based on the natural course of the disease, Light has classified pleural empyema according to the radiological, physical and biochemical characteristics, and the American College of Chest Physician (ACCP) has categorised the patients with pleural empyema according to the risk of a poor outcome. According to this classification the management of the pleural empyema is based on the stage of the disease. Therapeutic strategies include chest tube, chest tube with fibrinolysis, thoracoscopic debridement and decortication in open or minimally invasive techniques. Primary lung abscesses develop in previously healthy lung parenchyma and are caused by aspiration. In addition, abscess formation can occur without aspiration, and important differences relate to community-acquired, nosocomial abscesses and those in the immunosuppressed host. 90 % of all lung abscesses can be cured with antibiotic treatment alone, 10 % have to be treated with an interventional catheter or chest tubes and only 1 % require thoracic surgery because of complications independent of the former conservative or interventional treatment strategies.

Schlüsselwörter

Pleuraempyem - Lungenabszess - chirurgische Technik - VATS - Thoraxchirurgie - Antibiotikatherapie

Key words

pleural empyema - lung abscess - surgical technique - VATS - thoracic surgery - antibiotic strategies
 

  • Literatur

  • 1 Paris F, Deslauriers J, Calvo V et al. Empyema and bronchopleural fistula. In: Pearson FG. Thoracic Surgery. 2nd. edition NY: Churchill Livingstone; 2002: 1281-1300
    Google Scholar
  • 2 Maskell NA, Davies RJ. Effusions from parapneumonic infection and empyema. In: Light RW, Carry LeeYC. Textbook of Pleural Diseases. 1st. edition Arnold; 2003: 310-328
    Google Scholar
  • 3 Peters RM. Empyema thoracis: historical perspective. Ann Thorac Surg 1989; 48 (02) 306-308
    CrossrefPubMedGoogle Scholar
  • 4 Silen Ml, Naunheim KS. Thoracoscopic approach to the management of empyema thoracis: indications and results. Chest Surg Clin N Am 1996; 6: 491-499
    PubMedGoogle Scholar
  • 5 Angelillo Mackinlay TA, Lyons GA, Chimondeguy DJ et al. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema. Ann Thorac Surg 1996; 61 (06) 1626-1630
    CrossrefPubMedGoogle Scholar
  • 6 Andrews NC, Parker EF, Shaw RR et al. Management of nontuberculous empyema. Am Rev Respir Dis 1962; 85: 935-936
    PubMedGoogle Scholar
  • 7 Coote N, Kay E. Surgical versus non-surgical management of pleural empyema. Cochrane Database Syst Rev; 19.10.2005 CD001956
    PubMedGoogle Scholar
  • 8 Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108 (02) 299-301
    CrossrefPubMedGoogle Scholar
  • 9 Davies CW, Gleeson FV, Davies RJ. Pleural Diseases Group. Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax 2003; 58 (Suppl. 02) ii18-ii28
    PubMedGoogle Scholar
  • 10 Roberts JR. Minimally invasive surgery in the treatment of empyema: intraoperative decision making. Ann Thorac Surg 2003; 76 (01) 225-230
    CrossrefPubMedGoogle Scholar
  • 11 Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156
    PubMedGoogle Scholar
  • 12 Cassina PC, Hauser M, Hillejan L et al. Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. J Thorac Cardiovasc Surg 1999; 117 (02) 234-238
    CrossrefPubMedGoogle Scholar
  • 13 Thourani VH, Brady KM, Mansour KA et al. Evaluation of treatment modalities for thoracic empyema: a cost-effectiveness analysis. Ann Thorac Surg 1998; 66 (04) 1121-1127
    CrossrefPubMedGoogle Scholar
  • 14 Colice GL, Curtis A, Deslauriers J et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118 (04) 1158-1171
    CrossrefPubMedGoogle Scholar
  • 15 Light RW, Girard WM, Jenkinson SG et al. Parapneumonic effusions. Am J Med 1980; 69 (04) 507-512
    CrossrefPubMedGoogle Scholar
  • 16 Waller DA, Rengarajan A. Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg 2001; 71 (06) 1813-1816
    CrossrefPubMedGoogle Scholar
  • 17 Solaini L, Prusciano F, Bagioni P. Video-assisted thoracic surgery in the treatment of pleural empyema. Surg Endosc 2007; 21 (02) 280-284
    CrossrefPubMedGoogle Scholar
  • 18 Podbielski FJ, Maniar HS, Rodriguez HE et al. Surgical strategy of complex empyema thoracis. JSLS 2000; 4 (04) 287-290
    PubMedGoogle Scholar
  • 19 Striffeler H, Gugger M, Im Hof V et al. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. AnnThorac Surg 1998; 65 (02) 319-323
    CrossrefPubMedGoogle Scholar
  • 20 Kim BY, Oh BS, Jang WC et al. Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema. Am J Surg 2004; 188 (03) 321-324
    CrossrefPubMedGoogle Scholar
  • 21 Luh SP, Chou MC, Wang LS et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 2005; 127 (04) 1427-1432
    CrossrefPubMedGoogle Scholar
  • 22 Angelillo-Mackinlay T, Lyons GA, Piedras MB et al. Surgical treatment of postpneumonic empyema. World J Surg 1999; 23 (11) 1110-1113
    CrossrefPubMedGoogle Scholar
  • 23 Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006; 3 (01) 75-80
    CrossrefPubMedGoogle Scholar
  • 24 Wurnig PN, Wittmer V, Pridun NS et al. Video-assisted thoracic surgery for pleural empyema. Ann Thorac Surg 2006; 81 (01) 309-313
    CrossrefPubMedGoogle Scholar
  • 25 Wait MA, Sharma S, Hohn J et al. A randomized trial of empyema therapy. Chest 1997; 111 (06) 1548-1551
    CrossrefPubMedGoogle Scholar
  • 26 Maskell NA, Davies CW, Nunn AJ. (MIST1) Group et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352: 865-874
    CrossrefPubMedGoogle Scholar
  • 27 Rahman NM, Maskell NA, West A et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365: 518-526
    CrossrefPubMedGoogle Scholar
  • 28 Diacon AH, Theron J, Schuurmans MM et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J RespirCrit Care Med 2004; 170: 49-53
    PubMedGoogle Scholar
  • 29 Landreneau RJ, Keenan RJ, Hazelrigg SR et al. Thoracoscopy for empyema and hemothorax. Chest 1996; 109 (01) 18-24
    CrossrefPubMedGoogle Scholar
  • 30 Shahin Y, Duffy J, Beggs D et al. Surgical management of primary empyema of the pleural cavity: 5 outcome of 81 patients. Interact Cardiovasc Thorac Surg 2010; 10: 565-567
    CrossrefPubMedGoogle Scholar
  • 31 Chan DT, Sihoe AD, Chan S et al. Surgical treatment for empyema thoracis: is video-assisted thoracic surgery “better” than thoracotomy?. Ann Thorac Surg 2007; 84: 225-231
    CrossrefPubMedGoogle Scholar
  • 32 Tong BC, Hanna J, Toloza EM et al. Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg 2010; 89: 220-225
    CrossrefPubMedGoogle Scholar
  • 33 Mandal AK, Thadepalli H, Mandal AK et al. Outcome of primary empyema thoracis: therapeutic and microbiologic aspects. Ann Thorac Surg 1998; 66: 1782-1786
    CrossrefPubMedGoogle Scholar
  • 34 Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg 2006; 76: 120-122
    CrossrefPubMedGoogle Scholar
  • 35 Cardillo G, Carleo F, Carbone L et al. Chronic postpneumonic pleural empyema: comparative merits of thoracoscopic versus open decortication. Eur J Cardiothorac Surg 2009; 36: 914-918
    CrossrefPubMedGoogle Scholar
  • 36 Drain AJ, Ferguson JI, Sayeed R et al. Definitive management of advanced empyema by two-window video-assisted surgery. Asian Cardiovasc Thorac Ann 2007; 15: 238-239
    CrossrefPubMedGoogle Scholar
  • 37 Melloni G, Carretta A, Ciriaco P et al. Decortication for chronic parapneumonic empyema: results of a prospective study. World J Surg 2004; 28: 488-493
    CrossrefPubMedGoogle Scholar
  • 38 Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91: 901-909
    CrossrefPubMedGoogle Scholar
  • 39 Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16: S248-S255
    CrossrefPubMedGoogle Scholar
  • 40 Ewig S, Schäfer H. [A new look at lung abscess. Clinical treatment-related classification. Pneumologie 2001; 55: 195-201
    PubMedGoogle Scholar
  • 41 Ewig S, Schäfer H. [Treatment of community-acquired lung abscess associatedwith aspiration]. Pneumologie 2001; 55: 431-437
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Darling G, Downey GP, Herridge MS. Bacterial infections of the lung. In: Paterrson GA, Pearson FG, Cooper GD. et al. Pearson’s Thoracic and esophageal Surgery. New York: Churchill Livingstone; 2008: 433-469
    Google Scholar
  • 43 Brook I. Anaerobic pulmonary infections in children. Pediatr Emerg Care 2004; 20: 636-640
    CrossrefPubMedGoogle Scholar
  • 44 Hagan JL, Hardy JD. Lung abscess revisited. A survey of 184 cases. Ann Surg 1983; 197: 755-762
    CrossrefPubMedGoogle Scholar
  • 45 Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110: 56-77
    PubMedGoogle Scholar
  • 46 Pohlson EC, McNamara JJ, Char C et al. Lung abscess: a changing pattern of the disease. Am J Surg 1985; 150: 97-101
    CrossrefPubMedGoogle Scholar
  • 47 Wiedemann HP, Rice TW. Lung abscess and empyema. Semin Thorac Cardiovasc Surg 1995; 7: 119-128
    PubMedGoogle Scholar
  • 48 Hammond JM, Potgieter PD, Hanslo D et al. The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess. Chest 1995; 108: 937-941
    CrossrefPubMedGoogle Scholar
  • 49 Noboru T, Naho K, Takashi I et al. Etiology and Outcome of Community-Acquired Lung Abscess. Respiration 2010; 80: 98-105
    CrossrefPubMedGoogle Scholar
  • 50 Bartlett JC, Gorbach SL, Tally FP et al. Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis 1974; 109: 510-518
    PubMedGoogle Scholar
  • 51 Naidich DP, McGuinness G. Pulmonary manifestations of AIDS: CT and radiographic correlations. Radiol Clin North Am 1991; 29: 999-1017
    PubMedGoogle Scholar
  • 52 van Sonnenberg E, D’Agostino HB, Casola G et al. Lung abscess: CT-guided drainage. Radiology 1991; 178: 347-351
    PubMedGoogle Scholar
  • 53 Trotman-Dickenson B. Radiology in the intensive care unit. Part 2. J Intensive Care Med 2003; 18: 239-252
    CrossrefPubMedGoogle Scholar
  • 54 Lambiase RE, Deyoe L, Cronan JJ et al. Percutaneous drainage of 335 consecutive abscesses: Results of primary drainage with 1 year follow-up. Radiology 1992; 184: 167-179
    CrossrefPubMedGoogle Scholar
  • 55 Henry CM, Nicholas JB. Pyogenic lung infections: factors for predicting clinical outcome of lung abscess and thoracic empyema. Curr Opin Pulm Med 2000; 6: 234-239
    CrossrefPubMedGoogle Scholar